SHP.L: Summary for SHIRE PLC ORD 5P - Yahoo Finance

UK Markets open in 7 hrs 24 mins

Shire plc (SHP.L)


LSE - LSE Delayed price. Currency in GBp
Add to watchlist
4,497.10+48.60 (+1.10%)
At close: 5:11PM BST
People also watch
SN.LWPP.LAZN.LSMIN.LSDR.L
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close4,448.50
Open4,471.00
Bid4,380.00 x 51000
Ask4,573.00 x 53800
Day's range4,452.00 - 4,507.00
52-week range2,707.19 - 5,377.00
Volume1,962,535
Avg. volume2,249,038
Market cap40.48B
Beta1.79
PE ratio (TTM)108.63
EPS (TTM)N/A
Earnings dateN/A
Dividend & yield0.26 (0.46%)
Ex-dividend dateN/A
1y target estN/A
  • Fool.co.uk2 days ago

    2 surging growth stocks set to beat the FTSE 100

    These two shares appear to be on the up and capable of outperforming the FTSE 100 (INDEXFTSE:UKX).

  • PR Newswire7 days ago

    Shire plc: Data Show A Bleeding Episode Occurs Every Three to 15 Seconds in People Living With Hemophilia Worldwide

    ZUG, Switzerland, April 17, 2017 /PRNewswire/ -- On World Hemophilia Day 2017, Shire challenges the community to collectively improve global standards of care for rare bleeding disorders   Shire plc (LSE: ...

  • Business Wire14 days ago

    PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases

    PatientsLikeMe and Shire plc (LSE: SHP, NASDAQ: SHPG) have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease. Shire, the global leader in rare diseases and other highly specialized conditions, will work with PatientsLikeMe to appropriately engage patients and caregivers at every stage of their journey. Through the creation of digitally-enabled research communities and tools, this multi-year collaboration will help those struggling with a rare disease to track and share their experience with others living with the same condition.